[Congressional Record Volume 158, Number 32 (Wednesday, February 29, 2012)]
[Senate]
[Pages S1143-S1144]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]
RARE DISEASE DAY
Mr. REID. Mr. President, I ask unanimous consent that the Senate
proceed to the consideration of S. Res. 383.
The PRESIDING OFFICER. Without objection, it is so ordered. The clerk
will report the resolution by title.
The bill clerk read as follows:
A resolution (S. Res. 383) designating February 29, 2012,
as ``Rare Disease Day.''
There being no objection, the Senate proceeded to consider the
resolution.
Mr. REID. Mr. President, I ask unanimous consent that the resolution
be agreed to, the preamble be agreed to, the motion to reconsider be
laid upon the table, with no intervening action or debate, and that any
statements relating to the measure be printed in the Record.
The PRESIDING OFFICER. Without objection, it is so ordered.
The resolution (S. Res. 383) was agreed to.
The preamble was agreed to.
The resolution, with its preamble, reads as follows:
S. Res. 383
Whereas rare diseases and disorders are those diseases and
disorders that affect a small patient population, which in
the United States is typically a population of fewer than
200,000 people;
Whereas, as of the date of approval of this resolution,
nearly 7,000 rare diseases affect 30,000,000 people and their
families in the United States;
Whereas children with rare genetic diseases account for
more than half of the population affected by rare diseases in
the United States;
Whereas many rare diseases are life-threatening and lack an
effective treatment;
Whereas rare diseases and disorders include epidermolysis
bullosa, progeria, sickle cell anemia, Tay-Sachs disease,
cystic fibrosis, many childhood cancers, and fibrodysplasia
ossificans progressiva;
Whereas people with a rare disease experience challenges
that include difficulty in obtaining an accurate diagnosis,
limited treatment options, and difficulty finding a physician
or treatment center with expertise in the disease;
Whereas great strides have been made in research and
treatment for rare diseases as a result of the Orphan Drug
Act (21 U.S.C. 360aa et seq.);
Whereas both the Food and Drug Administration and the
National Institutes of Health have established special
offices to advocate for rare disease research and treatments;
Whereas the National Organization for Rare Disorders, an
organization established in 1983 to provide services to, and
advocate on behalf of, patients with rare diseases, was a
primary force behind the enactment of the Orphan Drug Act and
remains a critical public voice for people with rare
diseases;
Whereas the National Organization for Rare Disorders
sponsors Rare Disease Day in the United States to increase
public awareness of rare diseases;
Whereas Rare Disease Day has become a global event that
occurs annually on the last day of February;
Whereas Rare Disease Day was observed in the United States
for the first time on February 28, 2009; and
Whereas Rare Disease Day is expected to be observed
globally in years to come, providing hope and information for
rare disease patients around the world: Now, therefore, be it
Resolved, That the Senate--
(1) designates February 29, 2012, as ``Rare Disease Day'';
(2) recognizes the importance of improving awareness and
encouraging accurate and early diagnosis of rare diseases and
disorders; and
[[Page S1144]]
(3) supports the commitment of the United States and all
countries to improving access to, and developing, new
treatments, diagnostics, and cures for rare diseases and
disorders.
____________________